Leidos Price Target Slump: Navigating Volatility in Space and Defense Stocks

Recent adjustments to Leidos Holdings, Inc. (LDOS) price targets are forcing investors to recalibrate their expectations within the space technology and defense sectors. The shift reflects a more cautious outlook on near-term earnings performance.

Analyst Adjustments and Valuation Shifts

Jefferies has slashed its price target for LDOS from $140 to $110, maintaining a Hold rating. This downward revision is primarily driven by the expectation that fiscal Q2 2026 earnings will represent the year's trough. A projected 3% decline in the company's Health unit is a key factor contributing to the more conservative growth outlook.

In contrast, Citi lowered its target from $178 to $138 but maintained a Buy rating. Citi's stance suggests that while price targets are being moderated, the underlying investment thesis remains intact due to sector-wide valuation dynamics.

Sector Divergence: Aerospace vs. Defense

Broader updates across the aerospace and defense sector reveal a nuanced landscape ahead of Q2 earnings:

■Jefferies anticipates a full-year organic growth rate of 3% for the company.

■Citi expects aerospace firms to deliver "big beats" with moderate guidance raises, whereas defense-focused names are expected to show more moderate results.

■Compressed valuation multiples in the defense group continue to offer potential upside for share prices.

While the defense sector remains a cornerstone of geopolitical hedging, the divergence between aerospace performance and defense earnings guidance suggests a selective approach is necessary. Investors should closely monitor the stability of organic growth in non-defense segments to gauge long-term resilience.